Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Jan 04, 2023 9:12pm
123 Views
Post# 35204035

RE:Dr. Kjetil Ask

RE:Dr. Kjetil AskLooks like he left McMaster as per his LINKEDIN profile? From the August CZO NR:

The expanded research program will be under the leadership of Dr. Ask, and Dr. Hoare at McMaster University. Additionally, Dr. Martin Kolb will join in co-leading the project. Dr. Kolb is a Professor within the Division of Respirology in the Department of Medicine and Pathology & Molecular Medicine and the Research Director of the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hospital. His research insight on mechanisms of lung injury, repair and fibrosis along with his clinical first-hand experience with several hundred patients on interstitial lung disease and COVID-19-induced lung fibrosis well positions him to be an invaluable additional expert to Drs. Ask and Hoare.
<< Previous
Bullboard Posts
Next >>